PRAVASTAX cpr 40 mg 100 pce
7680625140126
CH-62514
C10AA03
07.12.0.
1 / 3
google
Details
- Product number
- 6251403
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- pravastatinum natricum 40 mg, lactosum 210.9 mg, povidonum, crospovidonum, calcii hydrogenophosphas, natrii stearylis fumaras, cellulosum microcristallinum, carmellosum natricum conexum, E 104, E 133, pro compresso corresp. natrium 2.919 mg.
Articles (1)
Pravastax 40 mg, Tabletten
Tabletten
100
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
pravastatinum natricum
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum
|
210.9 MG | Substance | HBESI |
|
povidonum
|
- | Substance | HNIDK |
|
crospovidonum
|
- | Substance | HNIDK |
|
calcii hydrogenophosphas
|
- | Substance | HNIDK |
|
natrii stearylis fumaras
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
E 104
|
- | Substance | FIMDK |
|
E 133
|
- | Substance | FIMDK |
|
natrium
|
2.919 MG | Substance | HBESI |
Authorization holder
Drossapharm AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 62514
- Drug name
- Pravastax, Tabletten
- Galenic form
- TAB
- ATC Code
- C10AA03
- Authorization status
- Revoked/Withdrawn
- Authorization category
- Category C
- Dispensation category
- B
- First authorization
- 22/02/2012
- Authorization expiration date
- 20/02/2026
- IT number
- 07.12.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PRAVASTAX cpr 40 mg 100 pce
- Description (DE)
- PRAVASTAX Tabl 40 mg 100 Stk
- Market launch
- 22/02/2012
- Market withdrawal
- 16/03/2026
- Narcotic (BTM)
- No